title: A study of the efficacy and safety of albendazole (Zentel) in the treatment of intestinal helmenthiasis in Kenyan children less than 2 years of age.
abstract: One hundred children comprising of 57 males and 43 females aged between 8 and 24 months entered the study. 46 children had single and 54 children had multiple helminth infections. All children received albendazole 200 mg (10 ml) suspension as a single dose. Albendazole proved very effective and safe in the treatment of single and multiple helminth infections in children under 2 years of age, achieving cure rates of 100% in both Ascaris lumbricoides and Necator americanus respectively, 83% in Trichuris trichiura and 66% in Hymenolepis nana. Treatment of polyparasitism appears to be of benefit in improving nutritional status using haemoglobin concentrations as an index.
authors.forename: H O
authors.initials: HO
authors.lastname: Pamba
authors.forename: N O
authors.initials: NO
authors.lastname: Bwibo
authors.forename: C N
authors.initials: CN
authors.lastname: Chunge
authors.forename: B B
authors.initials: BB
authors.lastname: Estambale
mesh_terms: D015766:Albendazole / Q000627:therapeutic use*; D005260:Female; D006373:Helminthiasis / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male
chemical_list: D015766:Albendazole